Association of monocyte-lymphocyte ratio and proliferative diabetic retinopathy in the U.S. population with type 2 diabetes.
Wang H, Guo Z, Xu Y.
J Transl Med. 2022 May 13;20(1):219. doi: 10.1186/s12967-022-03425-4.
PMID:35562757
Diabetic retinopathy in type 1 diabetes patients in Western Norway.
Jansson RW, Hufthammer KO, Krohn J.
Acta Ophthalmol. 2018 Aug;96(5):465-474. doi: 10.1111/aos.13654. Epub 2018 Jan 25.
PMID:29369506
Functional and structural outcomes and complications after pars plana vitrectomy for severe features of proliferative diabetic retinopathy in type 1 and type 2 diabetes mellitus.
Kaźmierczak K, Żuchowski P, Stafiej J, Malukiewicz G.
Relationship between Proliferative Diabetic Retinopathy and Inflammatory Markers in Patients with Type 1 Diabetes in Brazil: A Nested Case Control Study.
Ophthalmologica. 2020;243(6):471-478. doi: 10.1159/000510879. Epub 2020 Aug 14.
PMID:32799201
Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus - A comparative observational study.
Kumar K, Baliga G, Babu N, Rajan RP, Kumar G, Mishra C, Chitra R, Ramasamy K.
Indian J Ophthalmol. 2021 Nov;69(11):3289-3295. doi: 10.4103/ijo.IJO_1293_21.
PMID:34708790
Time to Progression to Proliferative Diabetic Retinopathy in Patients With Type 2 Diabetes.
Kim IM, Radgoudarzi N, Chen EM, Liu J, Moussa K, Shantha JG, Tsui E, Gore C, Baxter SL, Porco TC, Arnold BF, Sun CQ.